and led by scientists from John Hopkins Medication found that two doses of psilocybin and supportive psychotherapy resulted in rapid, significant antidepressant effects.This Viewpoint examines how US states are reforming laws to permit usage of psychedelics for therapeutic use, but federal regulations take into account these brokers being Program I